Filtered By:
Infectious Disease: HIV AIDS
Management: Department of Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 24 results found since Jan 2013.
A New Lab-Made COVID-19 Virus Puts Gain-of-Function Research Under the Microscope
On October 14, a team of scientists at Boston University released a pre-print study reporting that they had created a version of SARS-CoV-2 combining two features of different, existing strains that boosted its virulence and transmissibility. Scientists and the public raised questions about the work, which refocused attention on such experiments, and prompted the U.S. government to investigate whether the research followed protocols for these kinds of studies.
The concerns surround what is known as gain-of-function studies, in which viruses, bacteria, or other pathogens are created in the lab—either intentionally or ...
Source: TIME: Science - October 27, 2022 Category: Science Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
What to Know About the Monkeypox Drug TPOXX —And Why It ’ s So Hard to Get
Monkeypox, which federal officials declared a public health emergency on August 4, is not as contagious as the other ongoing public health emergency in the U.S.: COVID-19. Monkeypox primarily spreads through contact with infected skin lesions. Theoretically, containing monkeypox should therefore be more feasible, as long as testing, vaccines, and treatments are accessible. But in reality, the rollouts of all three approaches have faced major challenges. Getting the antiviral drug tecovirimat, also known as TPOXX, is particularly difficult.
Here’s what to know about the antiviral drug treatment TPOXX.
What is TPOXX?
T...
Source: TIME: Health - August 9, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate monkeypox Source Type: news
New head of U.S. aid program for HIV/AIDS vows to refocus attention on the other, ‘silent’ pandemic
On 13 June, John Nkengasong, 58, was appointed the first African-born head of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), a program that helps more than 50 countries respond to their HIV/AIDS epidemics. Nkengasong, who grew up in Cameroon and became a U.S. citizen in 2007, previously ran the Africa Centres for Disease Control and Prevention (Africa CDC).
PEPFAR is credited with helping save more than 20 million lives since its inception in 2003. It had a $10.7 billion budget in 2021, more than half of it spent on HIV treatment and care. The agency has relied on an acting director since Deborah Birx...
Source: Science of Aging Knowledge Environment - July 5, 2022 Category: Geriatrics Source Type: research
What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health
You don’t want to be a virus in Dr. David Ho’s lab. Pretty much every day since the COVID-19 pandemic began, Ho and his team have done nothing but find ways to stress SARS-CoV-2, the virus that causes the disease. His goal: pressure the virus relentlessly enough that it mutates to survive, so drug developers can understand how the virus might respond to new treatments. As a virologist with decades of experience learning about another obstinate virus, HIV, Ho knows just how to apply that mutation-generating stress, whether by starving the virus, bathing it in antibodies that disrupt its ability to infect cells, ...
Source: TIME: Health - June 11, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 feature Genetics Magazine Source Type: news
NIH Slated for 7 percent Budget Cut
The President has proposed a $38.7 billion budget for the National Institutes of Health in fiscal year (FY) 2021. This translates to a $3 billion or 7 percent cut in the agency’s funding compared to FY 2020.
The NIH budget request includes a $50 million initiative to use artificial intelligence (AI) to develop a better understanding of the causes of chronic diseases and to identify early treatments. This plan is in line with the Administration’s “Industries of the Future” effort, which supports using and developing AI across sectors.
The budget would provide $50 million for the Childhood Cancer ...
Source: Public Policy Reports - February 18, 2020 Category: Biology Authors: AIBS Source Type: news
President Slashes NIH Funding by 13 percent
The National Institutes of Health (NIH) would receive $34.4 billion in FY 2020, roughly $4.7 billion or 13 percent below the levels enacted by Congress for FY 2019, according to the President’s Budget released on March 11.
The budget for NIH includes $492 million in funding made available through the 21st Century Cures Act and $150 million in mandatory funding. The leading biomedical research agency in the world would receive budget cuts across the board. All NIH centers are slated for budget reductions:
National Cancer Institute: -8.7 percent
National Heart, Lung, and Blood Institute: -14 percent
National Inst...
Source: Public Policy Reports - March 19, 2019 Category: Biology Authors: AIBS Source Type: news
Trump Wants to End HIV Within 10 Years. Here ’s What That Would Take, According to Experts
About 1.1 million Americans currently live with HIV, and approximately 40,000 are infected each year, according to federal data. But in his State of the Union address, President Donald Trump promised to “eliminate the HIV epidemic in the United States within 10 years” — a plan that hinges on a multi-agency push for better diagnosis, treatment and prevention in at-risk communities, health officials said Wednesday.
Trump introduced the plan during his annual address on Tuesday but offered few details. Health officials fleshed out the plan during a call with reporters on Wednesday.
The initiative will be ove...
Source: TIME: Health - February 6, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime HIV/AIDS onetime Source Type: news
The World Is Not Ready for the Next Pandemic
Across China, the virus that could spark the next pandemic is already circulating. It’s a bird flu called H7N9, and true to its name, it mostly infects poultry. Lately, however, it’s started jumping from chickens to humans more readily–bad news, because the virus is a killer. During a recent spike, 88% of people infected got pneumonia, three-quarters ended up in intensive care with severe respiratory problems, and 41% died.
What H7N9 can’t do–yet–is spread easily from person to person, but experts know that could change. The longer the virus spends in humans, the better the chance that i...
Source: TIME.com: Top Science and Health Stories - May 4, 2017 Category: Consumer Health News Authors: Bryan Walsh Tags: Uncategorized CDC Disease ebola Gates Foundation MERS outbreak pandemic Zika Source Type: news
How D.C.'s Mayor Plans To End The HIV Epidemic In The Capitol's Backyard
More than 13,000 people are living with HIV in Washington, D.C. That’s 2 percent of the city’s population, or double the rate that constitutes an “epidemic” in the eyes of the Centers for Disease Control and Prevention.
Nancy Mahon, global executive director of the MAC AIDS Fund, the philanthropic arm of the cosmetic company MAC, says it’s “shameful” that the infection rate is so high “in the backyard of our nation’s Capitol” ― especially given the United States’ leading role in funding international AIDS work.
While D.C.’s infection rate has falle...
Source: Healthy Living - The Huffington Post - December 2, 2016 Category: Consumer Health News Source Type: news
NIH Statement on World AIDS Day 2015
Originally posted at NIH News Releases on December 1, 2015
NIH Statement on World AIDS Day 2015
Follow the science to fast-track the end of AIDS.
Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases
Carl Dieffenbach, Ph.D., Director, Division of AIDS, NIAID
Francis S. Collins, M.D., Ph.D., NIH Director
When the first cases of what would become known as AIDS were reported in 1981, scientists and physicians did not know the cause and had no therapies to treat those who were infected. Times have changed and today physicians can offer their patients highly effective medicines that work as bot...
Source: Dragonfly - December 1, 2015 Category: Databases & Libraries Authors: Emily Glenn Tags: News from NIH Public Health Source Type: news
NIH Launches Initiative to Develop Long-Acting HIV Treatment and Prevention Tools
"The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, launched a major initiative to advance novel approaches to treat and prevent HIV infections based on broadly neutralizing antibodies (bNAbs) today. A public-private partnership has been established for this effort between NIAID and the global pharmaceutical company GlaxoSmithKline (GSK) to enable researchers to develop one or more bNAbs, which can stop a wide range of HIV strains from infecting human cells in the laboratory, into a product to treat or prevent HIV infection."
For more information, view the NIAID press release.
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 20, 2015 Category: Infectious Diseases Source Type: news
Availability of Pyrimethamine: Statement from Adult & Adolescent OI Guideline Panel
Pyrimethamine is recommended for treatment and/or prophylaxis of Toxoplasma encephalitis, Pneumocystis pneumonia, and Isospora infection. As of June 2015, pyrimethamine is no longer available in retail pharmacies in the United States. It is only available through a special pharmacy program (http://www.daraprimdirect.com/how-to-prescribe). If there is a delay in procuring pyrimethamine for a patient in whom it is needed for one of the above indications, please refer to the specific pathogen section for alternative drug regimens for treatment or prophylaxis. For patients with suspected or documented toxoplasmosis who do not ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - September 11, 2015 Category: Infectious Diseases Source Type: news
“Drugs That Fight HIV-1” Brochure Recently Updated
The National Institute of Allergy and Infectious Diseases (NIAID) recently updated the “Drugs That Fight HIV-1” brochure, which features images of FDA-approved antiretroviral medications, grouped by drug class and identified by both generic and brand names. The brochure is available in both English and Spanish. It can be a helpful tool for health care professionals to use when discussing HIV treatment with patients.
The brochure can be found in the HIV/AIDS Images section of Health Topics on our website. Contact our health information specialists by phone (1-800-448-0440) or e-mail (ContactUs@aidsinfo.nih...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - April 25, 2014 Category: Infectious Diseases Source Type: news
Recent HIV/AIDS News from NIAID
April 3, 2014: Future HIV Vaccine Research Must Consider Both Protective Immune Responses and Those That Might Increase Susceptibility to Infection
“Last year, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, held a scientific meeting to examine why certain investigational HIV vaccines may have increased susceptibility to HIV infection. In a new perspectives article appearing in the journal Science, HIV research leaders from NIAID (Anthony S. Fauci, M.D., and Carl W. Dieffenbach, Ph.D.) and its grantees at Emory University (Eric Hunter, Ph.D.) and the ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - April 11, 2014 Category: Infectious Diseases Source Type: news
